Package 72189-057-30

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72189-057-30
Digits Only 7218905730
Product NDC 72189-057
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-057-30)

Marketing

Marketing Status
Marketed Since 2019-11-08
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2c4ea3ff-7a39-c7f4-e063-6294a90a5746", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993541", "993557"], "spl_set_id": ["96d87edc-d12b-44b2-e053-2995a90a4e63"], "manufacturer_name": ["DIRECT RX"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-057-30)", "package_ndc": "72189-057-30", "marketing_start_date": "20191108"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-057-60)", "package_ndc": "72189-057-60", "marketing_start_date": "20191108"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "72189-057_2c4ea3ff-7a39-c7f4-e063-6294a90a5746", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "72189-057", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "DIRECT RX", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA202304", "marketing_category": "ANDA", "marketing_start_date": "20191108", "listing_expiration_date": "20261231"}